Literature DB >> 3053205

Use of selected combinations of monoclonal antibodies to tumor associated antigens in the diagnosis of neoplastic effusions of unknown origin.

M Mottolese1, I Venturo, R P Donnorso, C G Curcio, M Rinaldi, P G Natali.   

Abstract

While conventional cytodiagnosis can, in most instances, recognize cancer cells in metastatic effusions from solid tumors, the cellular type or the organ of origin of the primary neoplasia can rarely be determined only on the basis of their morphology. In the present study we have evaluated whether immunocytochemical techniques can be used to overcome this limitation by employing a panel of monoclonal antibodies (MoAbs) to tumor associated antigens (TAA) which lack detectable reactivity with mesothelial cells. To this end we have analyzed, by indirect immunofluorescence, cytospins of 60 malignant effusions of unknown origin. The results of this study have shown that the definition of the origin of the primary tumor, which was subsequently confirmed histologically and/or clinically, could be reached in 87% of the cases. These findings demonstrate that selected combinations of MoAbs, when used in immunocytochemical tests, can provide a powerful diagnostic tool in defining the site of cryptic primary neoplasias causing metastatic effusions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053205     DOI: 10.1016/0277-5379(88)90215-5

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  8 in total

1.  Use of monoclonal antibodies in solid tumors diagnosis-the endometrial carcinoma.

Authors:  A Bartolazzi; M Mottolese; A Vocaturo; G Vocaturo; A Bigotti; M Prat; G A Giorgio Natali
Journal:  Cytotechnology       Date:  1991-02       Impact factor: 2.058

2.  Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific monoclonal antibodies.

Authors:  L B DeMonte; P Nistico; R Tecce; P Dellabona; M Momo; A Anichini; M Mariani; P G Natali; F Malavasi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

3.  Selective changes in expression of HLA class I polymorphic determinants in human solid tumors.

Authors:  P G Natali; M R Nicotra; A Bigotti; I Venturo; L Marcenaro; P Giacomini; C Russo
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

4.  Generation and characterization of two human alpha/beta T cell clones. Recognizing autologous breast tumor cells through an HLA- and TCR/CD3-independent pathway.

Authors:  P Nisticò; P De Berardinis; S Morrone; T Alonzi; C Buono; I Venturo; P G Natali
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

5.  The search for tumor-associated proteins in pleural effusions by means of monoclonal antibodies and a dot blot assay.

Authors:  M Lawniczak; J Sikora; P Kania; J Zeromski
Journal:  Lung       Date:  1992       Impact factor: 2.584

6.  Identification of second malignancies on effusions and fine-needle aspirates using a panel of monoclonal antibodies.

Authors:  M Mottolese; I Venturo; M Rinaldi; M Lopez; G Bigotti; M Benevolo; P G Natali
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Use of MoAb D612 in combination with a panel of MoAb for the immunocytochemical identification of metastases from colon-rectum carcinoma.

Authors:  M Mottolese; I Venturo; G Digiesi; R Perrone Donnorso; A Bigotti; R Muraro; A Aluffi; P G Natali
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

8.  How should cancer presenting as a malignant pleural effusion be managed?

Authors:  H Bonnefoi; I E Smith
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.